U.S. Food and Drug Administration

Don't delay, get your COVID-19 vaccine or booster today!

Getting vaccinated or receiving a booster if you’re already vaccinated is the best thing you can do to help protect yourself, family and friends.

Vaccines.gov

Collage of images including drug vials with syringe, 3D rendering of coronavirus, and closeup of a person being administered a shot

Featured

FDA COVID-19 Response

FDA is working with U.S. government partners, including CDC, and international partners to address the pandemic.

Click here to view the Acting Commissioner's report

Food

Drugs

Medical Devices

Radiation-Emitting Products

Vaccines, Blood, and Biologics

Animal and Veterinary

Cosmetics

Tobacco Products

New Era of Smarter Food Safety

A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.

Science-related icons juxtoposed on a background of prescription paperwork

Fostering Drug Competition

Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.

Closeup shot of a nurse holding a patient's hand in comfort in a hospital

Combating the Opioid Crisis

FDA takes actions to combat prescription opioid abuse.

Jan 18

FDA Roundup: January 18, 2022

Jan 18

FDA Releases CDRH Health of Women Strategic Plan to Better Inform Medical Device Research and Regulation for All Women

More Press Announcements

Newsroom Meetings Testimony Speeches

Jan 19

Amy’s Kitchen Voluntarily Issues Allergy Alert on Undeclared Milk in a Single Lot of Vegan Organic Rice Mac & Cheeze

Food & Beverages

Jan 19

Frozen Food Development Recalls Lidl Branded Chopped Spinach Because of Possible Health Risk

Food & Beverages

Jan 18

Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Recall of One Batch of Semglee® (insulin glargine injection), 100 units/mL (U-100), 3 mL Prefilled Pens, Due to the Potential for a Missing Label in the Batch

Drugs

More Recalls Market Withdrawals & Safety Alerts Subscribe to the Enforcement Report Mailing List

Paragraph Header

New Drug Therapy Approvals 2021. Patient holding handful of miscellaneous pills.

Many Important Drugs Approved in 2021 as COVID-19 Pandemic Continues

CDER approved a wide variety of safe and effective new drug therapies in 2021 despite challenges brought on by the ongoing COVID-19 pandemic.

Abstract image of doctor in background, x-ray of human body in center foreground surrounded by medical icon graphics.

Looking Ahead to 2022 as FDA’s Center for Devices and Radiological Health Manages a Sustained Increase in Workload

While CDRH’s response to the pandemic remains a top priority, we anticipate a gradual transition back toward normal review timelines in 2022.

Collage of FDA images. Left image of scientist looking through microscope. Top middle image of two Public Health Service officers at computer. Top right image of FDA inspector holding confiscated drugs in warehouse. Bottom right image of grocery store aisle and overlay of nutrition label. Middle image of scientists in lab running tests. Middle bottom image of abstract technology background.

Fulfilling Essential Public Health Needs in 2022

The FDA’s public health mission, although most apparent during emergencies, is in operation every day of every year, protecting Americans from many threats.

More FDA Voices

Jan 11

Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act

Biologics, Medical Devices

Jan 07